FI49497C - Menetelmä terapeuttisesti vaikuttavien 1-fenoksi-2-3-alkyyliaminopropa anien valmistamiseksi. - Google Patents

Menetelmä terapeuttisesti vaikuttavien 1-fenoksi-2-3-alkyyliaminopropa anien valmistamiseksi.

Info

Publication number
FI49497C
FI49497C FI683535A FI353568A FI49497C FI 49497 C FI49497 C FI 49497C FI 683535 A FI683535 A FI 683535A FI 353568 A FI353568 A FI 353568A FI 49497 C FI49497 C FI 49497C
Authority
FI
Finland
Prior art keywords
alkylaminopropanes
phenoxy
preparation
therapeutically active
therapeutically
Prior art date
Application number
FI683535A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI49497B (de
Inventor
Herbert Koeppe
Werner Kummer
Helmut Staehle
Karl Zeile
Albrecht Engelhardt
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of FI49497B publication Critical patent/FI49497B/fi
Application granted granted Critical
Publication of FI49497C publication Critical patent/FI49497C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI683535A 1967-12-13 1968-12-11 Menetelmä terapeuttisesti vaikuttavien 1-fenoksi-2-3-alkyyliaminopropa anien valmistamiseksi. FI49497C (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1643262A DE1643262C3 (de) 1967-12-13 1967-12-13 i-Phenoxy^-hydroxy-S-alklyaminopropane, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel

Publications (2)

Publication Number Publication Date
FI49497B FI49497B (de) 1975-04-01
FI49497C true FI49497C (fi) 1975-07-10

Family

ID=5684274

Family Applications (1)

Application Number Title Priority Date Filing Date
FI683535A FI49497C (fi) 1967-12-13 1968-12-11 Menetelmä terapeuttisesti vaikuttavien 1-fenoksi-2-3-alkyyliaminopropa anien valmistamiseksi.

Country Status (21)

Country Link
US (1) US3872147A (de)
JP (1) JPS5220457B1 (de)
AT (13) AT292670B (de)
BE (1) BE725490A (de)
BG (9) BG17298A3 (de)
BR (1) BR6804840D0 (de)
CA (1) CA954528A (de)
CH (2) CH532015A (de)
DE (1) DE1643262C3 (de)
DK (1) DK131029B (de)
ES (11) ES361189A1 (de)
FI (1) FI49497C (de)
FR (2) FR1596100A (de)
GB (1) GB1260866A (de)
HU (1) HU162734B (de)
IE (1) IE32758B1 (de)
IL (1) IL31266A (de)
NL (3) NL146709B (de)
PH (1) PH9266A (de)
SE (1) SE367396B (de)
YU (12) YU33949B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3541130A (en) * 1967-02-06 1970-11-17 Boehringer Sohn Ingelheim 1-(cyanophenoxy)-2-hydroxy-3-tert.-butylamine propanes
US4086272A (en) * 1970-07-18 1978-04-25 Pfizer Inc. Phenyl-alkanolamine, alkylamine and alpha-aminoalkyl ketone derivatives as heart stimulants
US3998874A (en) * 1971-03-23 1976-12-21 Gist-Brocades N.V. Phenylene di-ethers
US4038414A (en) * 1972-06-08 1977-07-26 Ciba-Geigy Corporation Amines and processes for their manufacture
DE2309887C2 (de) * 1973-02-28 1983-11-10 C.H. Boehringer Sohn, 6507 Ingelheim 1-Aryloxy-2-hydroxy-3-alkinylaminopropan-Derivate und deren physiologisch verträgliche Säureadditionssalze, pharmazeutische Präparate und Herstellungsverfahren für die Verbindungen
US4084002A (en) * 1973-02-28 1978-04-11 Boehringer Ingelheim Gmbh Pharmaceutical compositions containing a 1-phenoxy-2-hydroxy-3-alkynylamino-propane and method of use
US4161530A (en) * 1975-01-06 1979-07-17 Ciba-Geigy Corporation Pharmaceutical combination preparations as hypnotics
US4094991A (en) * 1975-06-17 1978-06-13 Nippon Shinyaku Co., Ltd. Substituted n-(carboxymethyl)-3-aminopropan-2-ol derivatives
US4243681A (en) * 1977-10-11 1981-01-06 Mead Johnson & Company Alkylthiophenoxypropanolamines and pharmaceutical compositions and uses thereof
DE2839475A1 (de) * 1978-09-11 1980-03-20 Dolorgiet Arzneimittelfabrik Isopropylamin-verbindungen, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE3062216D1 (en) * 1979-09-06 1983-04-07 Beecham Group Plc Cinnamic acid derivatives, their preparation, and pharmaceutical compositions containing them
JPS56142262A (en) 1980-04-08 1981-11-06 Nippon Shinyaku Co Ltd Piperazine derivative
US4593119A (en) * 1980-11-28 1986-06-03 American Hospital Supply Corporation Method for treatment or prophylaxis of cardiac disorders
US4387103A (en) * 1980-11-28 1983-06-07 American Hospital Supply Corporation Method for treatment or prophylaxis of cardiac disorders
US4405642A (en) * 1980-11-28 1983-09-20 American Hospital Supply Corporation Method for treatment or prophylaxis of cardiac disorders
US4396629A (en) * 1980-12-29 1983-08-02 Sterling Drug Inc. Compositions, processes and method
DE3131527A1 (de) * 1981-08-08 1983-02-24 Kali-Chemie Pharma Gmbh, 3000 Hannover 1-phenyl-2-aminocarbonylindol-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
AU575153B2 (en) * 1984-04-09 1988-07-21 Du Pont Merck Pharmaceutical Company, The Pharmaceutical compositions and method for treatment for prophylaxis of cardiac disorders
US4652584A (en) * 1984-07-13 1987-03-24 Mcneilab, Inc. Acetylenic phenoxypropanol derivatives and pharmaceutical compositions for the treatment of hypertension
US4665094A (en) * 1985-08-29 1987-05-12 Merck & Co., Inc. Oculoselective beta-blockers for treatment of elevated intraocular pressure
ATE45724T1 (de) * 1985-12-24 1989-09-15 Merck & Co Inc Okuloselektive betablocker.
US4945182A (en) * 1985-12-24 1990-07-31 Merck & Co., Inc. Oculoselective beta-blockers
US5480908A (en) * 1993-12-13 1996-01-02 American Cyanamid Company β3 -adrenergic agents benzodioxole dicarboxylates and their use in pharmaceutical compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3459782A (en) * 1963-08-26 1969-08-05 Boehringer Sohn Ingelheim 1-substituted phenoxy-2-hydroxy-3-isopropylamino-propanes

Also Published As

Publication number Publication date
YU237474A (en) 1977-12-31
ES375447A1 (es) 1972-05-01
YU237874A (en) 1977-12-31
NL7501794A (nl) 1975-05-30
YU237574A (en) 1978-02-28
YU33774B (en) 1978-05-15
ES375452A1 (es) 1972-05-16
ES375445A1 (es) 1972-05-16
YU33856B (en) 1978-06-30
YU237774A (en) 1978-02-28
AT292681B (de) 1971-08-15
YU238074A (en) 1977-12-31
ES375451A1 (es) 1972-05-01
YU237974A (en) 1977-12-31
YU33852B (en) 1978-06-30
DK131029C (de) 1975-10-06
NL7501792A (nl) 1975-05-30
FR8328M (de) 1970-12-07
FR1596100A (de) 1970-06-15
FI49497B (de) 1975-04-01
ES375453A1 (es) 1972-05-16
BG16445A3 (bg) 1972-11-20
BG16330A3 (bg) 1972-08-20
YU33948B (en) 1978-09-08
YU33853B (en) 1978-06-30
YU33946B (en) 1978-09-08
YU294968A (en) 1978-02-28
US3872147A (en) 1975-03-18
CH532015A (de) 1972-12-31
AT298463B (de) 1972-05-10
IL31266A (en) 1974-09-10
NL151354B (nl) 1976-11-15
YU238274A (en) 1977-12-31
ES375450A1 (es) 1972-05-01
DE1643262B2 (de) 1974-11-07
BG16331A3 (bg) 1972-08-20
YU33851B (en) 1978-06-30
AT298459B (de) 1972-05-10
AT294799B (de) 1971-12-10
AT292677B (de) 1971-09-10
NL6817768A (de) 1969-06-17
DE1643262C3 (de) 1975-06-26
AT292679B (de) 1971-09-10
BG17298A3 (de) 1973-07-25
AT292678B (de) 1971-09-10
YU237674A (en) 1977-10-31
BG17297A3 (de) 1973-07-25
ES375444A1 (es) 1972-05-01
NL146709B (nl) 1975-08-15
YU33854B (en) 1978-06-30
GB1260866A (en) 1972-01-19
ES375449A1 (es) 1972-05-01
ES375448A1 (es) 1972-05-01
SE367396B (de) 1974-05-27
ES375446A1 (es) 1972-05-01
YU33773B (en) 1978-05-15
YU33947B (en) 1978-09-08
DK131029B (da) 1975-05-20
DE1643262A1 (de) 1972-04-20
IL31266A0 (en) 1969-02-27
ES361189A1 (es) 1970-08-16
AT292670B (de) 1971-09-10
YU238474A (en) 1978-02-28
BE725490A (de) 1969-06-13
YU33949B (en) 1978-09-08
IE32758L (en) 1969-06-13
AT292673B (de) 1971-09-10
HU162734B (de) 1973-04-28
AT292680B (de) 1971-09-10
BR6804840D0 (pt) 1973-03-08
BG19135A3 (de) 1975-04-30
BG16332A3 (bg) 1972-08-20
PH9266A (en) 1975-07-30
BG16444A3 (bg) 1972-11-20
YU238374A (en) 1977-12-31
AT292676B (de) 1971-09-10
AT292675B (de) 1971-09-10
BG16329A3 (bg) 1972-08-20
CH556816A (de) 1974-12-13
YU33855B (en) 1978-06-30
CA954528A (en) 1974-09-10
JPS5220457B1 (de) 1977-06-03
AT292674B (de) 1971-09-10
IE32758B1 (en) 1973-11-28
YU238174A (en) 1977-10-31

Similar Documents

Publication Publication Date Title
DK128353B (da) Analogifremgangsmåde til fremstilling af terapeutisk aktive bis-chromoner.
FI42712C (fi) Menetelmä terapeuttisesti vaikuttavien bifenyylialkaanijohdannaisten valmistamiseksi
FI49957C (fi) Menetelmä terapeuttisesti vaikuttavien oksiimieetterien valmistamiseks i.
FI49497C (fi) Menetelmä terapeuttisesti vaikuttavien 1-fenoksi-2-3-alkyyliaminopropa anien valmistamiseksi.
FI48727C (fi) Menetelmä asetyyliguanidiinien valmistamiseksi.
FI50707C (fi) Menetelmä uusien farmakologisesti vaikuttavien hydroksisykloheksyyliam iinien valmistamiseksi.
FI49720C (fi) Menetelmä terapeuttisesti vaikuttavien 2-metyyli-3-karbonihappoamidoki noksaliini-di-N-oksidien-(1,4) valmistamiseksi.
FI52857C (fi) Menetelmä terapeuttisesti vaikuttavien amidoksiimien valmistamiseksi.
FI45551C (fi) Menetelmä terapeuttisesti käytettävän dehydroepiandrosteroniönantaatin valmistamiseksi.
DK117635B (da) Analogifremgangsmåde til fremstilling af terapeutisk virksomme 3-(piperazinoalkyl)-pyrazoler.
FI49718C (fi) Menetelmä terapeuttisesti vaikuttavien 2-halogeenimetyyli-3-karbonihap poamidokinoksaliini-di-N-oksidien-(1,4) valmistamiseksi.
FI51175C (fi) Menetelmä terapeuttisesti käytettävien indanyylitiokarbamaattien valmi stamiseksi.
FI49032C (fi) Menetelmä terapeuttisesti aktiivisten 7-nitro-8-hydroksi-kinoliini-est erien valmistamiseksi.
FI50420C (fi) Menetelmä terapeuttisesti aktiivisten 4-pyrimidinyyli-1,4-dihydropyrid iinijohdannaisten valmistamiseksi
FI47189C (fi) Tapa valmistaa terapeuttisesti vaikuttavia d-lysergiinihappo-N-fenyyli piperatsideja.
FI48576C (fi) Menetelmä terapeuttisesti aktiivisten alfa-fluori-malonihappojohdannai sten valmistamiseksi.
FI46066C (fi) Analogiamenetelmä terapeuttisesti vaikuttavien N,N-dimetyyliamino-etyy li-14beta-hydroksi-5beta-pregn-20-eeni-21-karboksylaattien valmistamis eksi.
FI48190C (fi) Menetelmä terapeuttisesti aktiivisten 10alfa-metoksi-9,10-dihydroergol iinijohdannaisten valmistamiseksi
FI50879C (fi) Menetelmä terapeuttisesti vaikuttavien substituoitujen 3-aminoasyyliam ino-tiofeenien valmistamiseksi.
FI48841C (fi) Menetelmä farmakologisesti aktiivisten 5-nitro-2-furfuryylideeniamino- oksatsolidinonien valmistamiseksi.
FI45553C (fi) Menetelmä terapeuttisesti käytettävien 16-tiosubstituoitujen 9beta,10a lfa-pregneenien valmistamiseksi
FI47661C (fi) Menetelmä terapeuttisesti vaikuttavien bentsofuraanijohdannaisten valm istamiseksi.
FI47651C (fi) Menetelmä dityppitetroksidin valmistamiseksi.
FI49722C (fi) Menetelmä terapeuttisesti vaikuttavien 3-karbonihappoamidokinoksaliini -di-N-oksidien-(1,4) valmistamiseksi.
DK122763B (da) Analogifremgangsmåde til fremstilling af terapeutisk aktive 1,2α-methylen-4-pregnen-3,20-dionderivater.